Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3, Open-label, Randomized Trial to Evaluate the Safety and Efficacy of MP-376 Inhalation Solution (Aeroquin) vs. Tobramycin Inhalation Solution (TIS) in Stable CF Patients

NCT01270347 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT01270347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01270347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3, Open-label, Randomized Trial to Evaluate the Safety and Efficacy of MP-376 Inhalation Solution (Aeroquin) vs. Tobramycin Inhalation Solution (TIS) in Stable CF Patients
Lead sponsor
Amgen
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2011
Completion date
June 30, 2013
Enrollment
282 (actual)
Sites
130

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis